West Midlands HealthTech/MedTech ‘6D’ Innovation Accelerator

医疗保健技术和医疗技术部门目前每年为英国创造170亿英镑的价值，随着人口老龄化和疫情后健康状况不佳，预计到2027年每年将增长到210亿英镑。然而，这些行业的监管水平相对较高，可能会使新公司将其技术引入英国市场变得缓慢而昂贵，这阻碍了它们相对于其他全球竞争对手的增长。西米德兰兹郡的“6D”创新加速器（6D- ia）将联合该地区的主要参与者（大学、医院、工业和政府资助的制造业创新“弹射器”），通过创造一个支持性的环境来加速新技术的商业化，从而解决这些问题。合作伙伴将开展一系列集中协调的活动，帮助公司在医疗翻译过程中找到“关键点”。我们的“6d”包括对公司需求的诊断；NHS的定义或企业面临的挑战；开发和完善原型产品或服务；在现实世界的NHS环境中部署创新；跨部门合作多样化；以及我们干预措施的经济效益。这将在该领域形成一系列商业活动，有助于推动区域经济增长，增强抵御能力。它还将确保当地患者首先受益于旨在减少严重的区域保健不平等的新医疗技术。6D-IA还将为新的医疗保健技术的开发和部署提供国家重点，以新的精密医疗保健技术加速器为中心，发展一个充满活力和自我维持的活动集群，利用最近的主要私人投资和重要的区域资产来吸引和支持医疗创新者。6D-IA将把西米德兰兹郡置于英国医疗创新的前沿，通过加强大伯明翰地区的一系列活动，与强大的区域和国家联系。它将促进该地区的经济活动，到2026/27年吸引高达8000万至1亿英镑的额外私人投资。它还将通过大力关注开发新的数字化创新，为二级医疗提供强有力的原则证明，并在社区和初级医疗中开展相关试点工作，从而促进医疗保健服务的转型。

The Healthcare Technology and Medical Technology sectors are currently worth £17billion per annum to the UK, and with the ageing population and poor health following the pandemic, are projected to grow to £21billion per annum by 2027\. However, the relatively high levels of regulation in these sectors, can make it slow and expensive for new companies to bring their technologies to the UK market, something that has hindered growth comparative to other global competitors.The West Midlands '6D' Innovation Accelerator (6D-IA) will unite key players across the region (universities, hospitals, industry and government-funded 'Catapults' for manufacturing innovation) to address these problems by creating a supportive environment to accelerate new technologies towards commercialisation. The partners will run a centrally coordinated series of activities that will help companies to navigate "pinch-points" in the process of medical translation. Our '6Ds' include diagnosis of company needs; definition of NHS or corporate challenges to respond to; development and refinement of prototype products or services; deployment of innovation in real-world NHS settings; diversification of cross-sectoral collaborations; and demonstration of economic benefit for our interventions.Together, this will create a cluster of commercial activity in this sector, helping to drive regional economic growth and enhance resilience. It will also ensure that local patients will benefit first from new medical technologies targeted at reducing significant regional healthcare inequalities. The 6D-IA will also provide a national focus for the development and deployment of new healthcare technologies, growing a vibrant and self-sustaining cluster of activity centred in the new Precision Healthcare Technology Accelerator, leveraging major recent private investment alongside significant regional assets to attract and support medical innovators.The 6D-IA will place the West Midlands at the forefront of UK medical innovation by supercharging a cluster of activity in the Greater Birmingham area with strong regional and national links. It will boost economic activity within the region, attracting up to £80-100million in additional private investment by 2026/27\. It will also facilitate the transformation of the delivery of healthcare by creating a strong focus on the development of new digitally-enabled innovations, providing strong secondary care proof-of-principle with associated pilot work in community and primary care.